A Study to Evaluate the Effectiveness of Voriconazole + Micafungin Versus Voriconazole Alone for Invasive Aspergillosis

Inclusion Criteria: * Proven, probable or possible invasive aspergillosis * Patient is 2 years of age or older Exclusion Criteria: * The patient has been administered an antifungal agent (voriconazole, itraconazole, posaconazole, caspofungin, micafungin, anidulafungin, amphotericin B, or lipid formulation of amphotericin B) for \>7 days immediately prior to randomization for treatment of the Possible, Probable, or Proven invasive aspergillosis for which the patient is being enrolled. * The patient has been treated with voriconazole for \> 7 days immediately prior to randomization